norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis-Reference-Cited by-同舟云学术

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Published:2017-09 Issue:3 Volume:67 Page:549-558
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Fickert Peter,Hirschfield Gideon M.,Denk Gerald,Marschall Hanns-Ulrich,Altorjay Istvan,Färkkilä Martti,Schramm Christoph,Spengler Ulrich,Chapman Roger,Bergquist Annika,Schrumpf Erik,Nevens Frederik,Trivedi Palak,Reiter Florian P.,Tornai Istvan,Halilbasic Emina,Greinwald Roland,Pröls Markus,Manns Michael P.,Trauner Michael

Publisher

Elsevier BV

Subject

Hepatology

Reference44 articles.

1. Primary sclerosing cholangitis;Hirschfield;Lancet,2013

2. New therapeutic strategies for primary sclerosing cholangitis;Williamson;Semin Liver Dis,2016

3. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis;Karlsen;Aliment Pharmacol Ther,2014

4. EASL Clinical Practice Guidelines: management of cholestatic liver diseases;J Hepatol,2009

5. ACG clinical guideline: primary sclerosing cholangitis;Lindor;Am J Gastroenterol,2015

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversal of hepatic accumulation of nordeoxycholic acid underlines the beneficial effects of cholestyramine on alcohol-associated liver disease in mice;Hepatology Communications;2024-07-31

2. Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5;Phytotherapy Research;2024-07-20

3. The gut microbiota-bile acid axis in cholestatic liver disease;Molecular Medicine;2024-07-19

4. Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials;Expert Opinion on Emerging Drugs;2024-07-04

5. Immunology of bile acids regulated receptors;Progress in Lipid Research;2024-07